• Targeting Tumor Microenvironment Could Improve Response to Immunotherapies in Urothelial Cancer, Study Finds
  • Keytruda and Chemotherapy Combo Now 1st-Line Treatment for Advanced NSCLC in EU
  • ‘Switchable’ CAR T-cell Therapy Kills Advanced Pancreatic Cancer Cells in Mice, Study Reports
  • StemVacs Cancer Vaccine Shows Safety in Phase 1 Study and May Be Eligible for Right to Try, Therapeutic Solutions Says
  • Affimed and Genentech Partner to Develop Immunotherapies Against Cancer Based on Natural Killer Cells
  • New UNC Software Aims to Make Stem Cell Transplants Safer for Leukemia Patients
  • Adlai Nortye Opens Boston Site to Advance Cancer Treatments
  • Blocking Cellular Pathway May Make Radiotherapy More Effective by Activating Immune System, Early Study Reports
  • Mutations in MUC16 Gene May Help Define Immunotherapy Strategies for Gastric Cancer, Study Suggests
  • New Scoring System May Help Predict Patient Response to Checkpoint Inhibitors, Study Reports
  • High Nitrogen Levels Can Increase Cancer Cell Growth, But Also Enhance Immunotherapy Response, Study Suggests
  • Genprex, MD Anderson to Explore Oncoprex-Immunotherapies Combo in Broad Array of Cancers